Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline post-exposure prophylaxis for STI prevention in MSM using HIV PrEP
2019-002829-29Phase 4Completed
- Sponsor
- ANRS
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of doxycycline and emtricitabine + tenofovir disoproxil in sexually transmitted disease (STD), syphilis, Chlamydia trachomatis infection and 3 more (2 arms), sponsored by ANRS. Primary endpoint: First episode of chlamydia or syphilis after enrolment. Started Oct 2019; status: completed.
02
Drugs
doxycyclineemtricitabine + tenofovir disoproxil
03
Conditions
sexually transmitted disease (STD)syphilisChlamydia trachomatis infectiongonorrheaMycoplasma genitalium infection (Mgen)
Beyond the preview
Go deeper on 2019-002829-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002829-29.